The preferred-to-common conversion without new capital is a bearish signal of financial distress, as it dilutes existing common holders while providing no operating cash. The adjourned annual meeting with Nasdaq discussions raises the risk of a listing deficiency or delisting. Monitor the supplemental proxy filing and any Nasdaq compliance update.
Price Chart
Executive Summary
Jaguar Health issued 54,222 common shares to Streeterville Capital in exchange for the cancellation of 7.96 shares of Series Q Perpetual Preferred Stock, converting preferred equity into common stock without new cash proceeds. Separately, the company adjourned its 2026 Annual Meeting until June 2, 2026, after Nasdaq discussions prompted a supplemental proxy filing, signaling potential governance or compliance concerns.
Key Facts
- Issued 54,222 common shares to Streeterville Capital in exchange for 7.96 Series Q Preferred shares (cancelled and retired).
- No new cash raised — the exchange is a debt-to-equity conversion under Section 3(a)(9).
- Annual Meeting adjourned from May 22 to June 2, 2026, due to Nasdaq discussions requiring supplemental proxy information.
- Market cap is ~$49M; the 54,222 common shares represent a material dilution event relative to outstanding shares.
Financial Impact
54,222 common shares issued; no cash consideration received. Dilution impact depends on pre-exchange share count, which is not disclosed in the filing.
Risk Factors
- Nasdaq listing compliance risk — adjourned meeting suggests potential deficiency or delisting threat.
- Further dilution from additional Streeterville conversions or other financing arrangements.
- No new cash raised — the exchange does not address the company's liquidity needs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-237195 |
| Document: d138181dex102.htm | 0001193125-26-237195 |
| Document: d138181dex101.htm | 0001193125-26-237195 |
| Document: 0001193125-26-237195-index-headers.html | 0001193125-26-237195 |
| Document: 0001193125-26-237195-index.html | 0001193125-26-237195 |
| Document: 0001193125-26-237195.txt | 0001193125-26-237195 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | S-3 | $2.04 | awaiting T+60 | — | $2.37 (−16.18%) |
Oct 8, 2026 18d ago | DEF 14A | $4.79 | awaiting T+60 | — | $2.37 (+50.52%) |
Oct 5, 2026 21d ago | 8-K | $4.73 | awaiting T+60 | — | $2.37 (+49.89%) |
Sep 28, 2026 28d ago | 8-K | $6.02 | awaiting T+60 | — | $2.37 (+60.63%) |
Sep 24, 2026 4w ago | SC 13G/A | $7.70 | awaiting T+60 | — | $2.37 (+69.22%) |
Sep 24, 2026 4w ago | 424B5 | $7.06 | awaiting T+60 | — | $2.37 (+66.43%) |
Sep 24, 2026 4w ago | 8-K | $7.06 | awaiting T+60 | — | $2.37 (+66.43%) |
Sep 21, 2026 5w ago | 8-K | $34.46 | awaiting T+60 | — | $2.37 (−93.12%) |
Sep 15, 2026 5w ago | 8-K | $0.2246 | awaiting T+60 | — | $2.37 (−955.21%) |
Sep 3, 2026 7w ago | 424B5 | $10.41 | awaiting T+60 | — | $2.37 (+77.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers